Zinc and p53 disrupt mitochondrial binding of HK2 by phosphorylating VDAC1

Ya-Nan Xue1, Bing-Bing Yu1, Jiu-Ling Li1

  • 1Department of Pathophysiology, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, China.

Experimental Cell Research
|December 12, 2018
PubMed

Insights

Zinc and p53 disrupt the mitochondrial binding of hexokinase 2 (HK2) in prostate cancer cells, inhibiting tumor growth. This discovery offers a novel therapeutic strategy targeting cancer cell metabolism and apoptosis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Cell death regulators and metabolic enzymes interplay, offering insights into cancer therapy mechanisms.
  • Zinc and p53 induce apoptosis and regulate tumor cell metabolism, but the precise mechanisms are unclear.
  • Hexokinase 2 (HK2) possesses dual metabolic and apoptotic roles, making it a key target in cancer research.

Purpose of the Study:

  • To elucidate the mechanism by which zinc and p53 affect hexokinase 2 (HK2) function in prostate cancer.
  • To investigate the role of HK2's mitochondrial localization in prostate cancer cell apoptosis and metabolism.
  • To evaluate the therapeutic potential of targeting HK2 mitochondrial localization in prostate cancer.

Main Methods:

  • Analysis of zinc and p53 downstream targets in prostate cancer tissues and cell lines.
  • Investigation of HK2's subcellular localization, particularly its mitochondrial association.
  • Biochemical assays to determine the phosphorylation status of VDAC1 and its effect on HK2 binding.
  • Inhibition studies involving protein kinase B (Akt) and glycogen synthase kinase 3β (GSK3β).
  • Xenograft models to assess the in vivo efficacy of combined zinc and p53 treatment.

Main Results:

  • Hexokinase 2 (HK2) was identified as a downstream target of zinc and p53 in prostate cancer.
  • Mitochondrial localization of HK2 was found to be critical for its function.
  • Zinc and p53 were shown to disrupt HK2's mitochondrial binding by phosphorylating VDAC1, involving Akt inhibition and GSK3β activation.
  • Combined zinc and p53 treatment significantly inhibited tumor growth in a prostate cancer xenograft model.

Conclusions:

  • Zinc and p53 interfere with the mitochondrial localization of HK2 in prostate cancer cells.
  • This interference, mediated by VDAC1 phosphorylation, offers a novel mechanism for inducing apoptosis and inhibiting tumor metabolism.
  • Targeting HK2 mitochondrial localization presents a promising new therapeutic strategy for prostate cancer treatment.

Related Concept Videos

Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
53.9K
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
9.2K
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.2K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.0K
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes02:16

Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes

The present-day mitochondrial and chloroplast genomes have retained some of the characteristics of their ancestral prokaryotes and also have acquired new attributes during their evolution within eukaryotic cells. Like prokaryotic genomes, mitochondrial and chloroplast genomes neither bind with histone-like proteins nor show complex packaging into chromosome-like structures, as observed in eukaryotes. Unlike mitotic cell divisions observed in eukaryotic cells, mitochondria and chloroplasts...
16.1K
Export of Mitochondrial and Chloroplast Genes02:19

Export of Mitochondrial and Chloroplast Genes

A eukaryotic cell can have up to three different types of genetic systems: nuclear, mitochondrial, and chloroplast. During evolution, organelles have exported many genes to the nucleus; this transfer is still ongoing in some plant species. Approximately 18% of the Arabidopsis thaliana nuclear genome is thought to be derived from the chloroplast’s cyanobacterial ancestor, and around 75% of the yeast genome derived from the mitochondria’s bacterial ancestor. This export has occurred...
4.2K